-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Shijiazhuang Sihua Pharmaceutical Group Makes Its Debut at the 2024 Natural, Healthy and Innovative Ingredients (Western) Exhibition in the United States
Category:
发布时间：2024-10-31
【概要描述】
On the morning of October 30, local time, the 2024 U.S. Natural, Health and Innovative Ingredients (West) Expo opened in Las Vegas. Shijiazhuang Sihua Pharmaceutical Group showcased its presence at the event and is actively expanding into international markets.
On the morning of October 30, local time, the 2024 U.S. Natural, Health and Innovative Ingredients (Western) Exhibition opened in Las Vegas. Shijiazhuang Sihua Pharmaceutical Group showcased its presence at the event and is actively expanding into international markets.
The Natural, Healthy and Innovative Ingredients (West) Exhibition in the United States is organized by Informa Exhibitions, the world’s largest exhibition group. Held annually in the eastern and western regions of the U.S., respectively, the event has been successfully staged 26 times to date, establishing itself as one of the world’s leading international trade shows for plant extracts, health-food ingredients, functional-food ingredients, pharmaceutical raw materials, and beauty-and-cosmetics ingredients.
In recent years, leveraging the industrialization advantages of its two major API production bases—Hebei Guangxiang Pharmaceutical Co., Ltd. and Hebei Guolong Pharmaceutical Co., Ltd.—the Group has steadily accelerated its integrated “API-plus-formulation” development model, seamlessly integrating both bulk and specialty APIs to continually enrich and diversify its product portfolio. Through a strategy of “going global while inviting partners in,” the Group has established long-term, trust-based partnerships with numerous food and pharmaceutical companies worldwide, effectively boosting the international expansion of API products such as caffeine, theophylline, aminophylline, and azithromycin. As a result, the Group’s network of international business relationships has continued to grow, and its level of international operations has improved markedly.
At the group’s booth, a clean and dynamic design ethos underscores its commitment to openness, collaboration, and win-win partnerships. The wealth of product information on display has drawn the attention of international business visitors, who have eagerly approached the group’s trade representatives to learn more about the company and its offerings.
“We must seize the opportunity presented by this trade fair to promote our flagship, competitive products such as caffeine and azithromycin, while fully showcasing the numerous new API products developed by our company over the past two years, thereby enabling more international buyers and partners to gain a deeper understanding of Shijiazhuang Sihua Pharmaceutical Group’s robust R&D, manufacturing, and service capabilities,” said Wu Hengyao, the group’s president who led the delegation. He added that by leveraging the international exhibition platform to engage in in-depth exchanges and negotiations with customers and partners from around the world, the company can further consolidate and deepen existing customer relationships, expand its base of new clients, build a broader global business network and partnership framework, and inject fresh momentum and vitality into its international business development.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091